| A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body (NCT07221591) | Boehringer Ingelheim | 2025-11-05 |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) (NCT06888193) | UCB Biopharma SRL | 2025-11-05 |
| A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma. (NCT07258979) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2025-11-05 |
| A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017) (NCT07219550) | Merck Sharp & Dohme LLC | 2025-11-05 |
| THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy (NCT06859710) | University of California, Los Angeles | 2025-11-05 |
| A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (NCT07215260) | Boehringer Ingelheim | 2025-11-05 |
| A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants (NCT07229404) | Bayer | 2025-11-05 |
| A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants (NCT07235774) | Institut de Recherches Internationales Servier (I.R.I.S.) | 2025-11-05 |
| Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions (NCT07260851) | Daewoong Pharmaceutical Co. LTD. | 2025-11-05 |
| A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT07219511) | Vasa Therapeutics | 2025-11-04 |
| Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants (NCT07220889) | MDI Therapeutics, Inc. | 2025-11-04 |
| PULSAR Combined With Immunotherapy and Chemotherapy (NCT07291947) | Wang Xin | 2025-11-04 |
| Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma (NCT07245368) | Prana Therapies Inc | 2025-11-04 |
| Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors (NCT07243470) | Centre Leon Berard | 2025-11-04 |
| FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors (NCT07216105) | Fate Therapeutics | 2025-11-04 |
| A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer (NCT07189403) | Daiichi Sankyo | 2025-11-04 |
| A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing (NCT06066138) | National Cancer Institute (NCI) | 2025-11-04 |
| Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity (NCT07245771) | Ikaria Bioscience Pty Ltd | 2025-11-04 |
| CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases (NCT07247396) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-11-03 |
| A Study of How the Body Absorbs LY3537031 (NCT07202871) | Eli Lilly and Company | 2025-11-03 |
| Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT07214961) | ARTBIO Inc. | 2025-11-03 |
| Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa (NCT07049575) | Incyte Corporation | 2025-11-03 |
| A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) (NCT07064122) | AstraZeneca | 2025-11-03 |
| Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis (NCT07228325) | Nasus Pharma | 2025-11-03 |
| A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults. (NCT07284173) | Pfizer | 2025-11-03 |
| Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer (NCT07377331) | Texas Christian University | 2025-11-01 |
| Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease (NCT07238985) | Tanta University | 2025-11-01 |
| DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau (NCT07142278) | Nuravax, Inc. | 2025-11-01 |
| Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE (NCT07233642) | The Children's Hospital of Zhejiang University School of Medicine | 2025-11-01 |
| A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects (NCT07126704) | 1ST Biotherapeutics, Inc. | 2025-11-01 |
| A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC (NCT07244705) | Anbogen Therapeutics, Inc. | 2025-11-01 |
| Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer (NCT07090369) | Peter MacCallum Cancer Centre, Australia | 2025-11-01 |
| Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution (NCT07075224) | Unither Pharmaceuticals, France | 2025-11-01 |
| Fish Oil, Metformin and Heart Health in PCOS (NCT06424860) | University of Alberta | 2025-11-01 |
| hUC-MSC-Exo Therapy for Autoimmune Encephalitis (NCT07131683) | Xuanwu Hospital, Beijing | 2025-11-01 |
| AD-SVF Therapy for Refractory Endometrial Infertility (NCT07230600) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2025-11-01 |
| BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma (NCT06608940) | Case Comprehensive Cancer Center | 2025-11-01 |
| Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease (NCT07544888) | Shaikh Zayed Hospital, Lahore | 2025-11-01 |
| Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults (NCT06367738) | University of California, Berkeley | 2025-11-01 |
| Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Ketamine in Reducing Postoperative Pain After Total Abdominal Hystrectomy (NCT07482709) | Liaquat National Hospital & Medical College | 2025-11-01 |
| Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects (NCT07490353) | Medical University of Vienna | 2025-11-01 |
| Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism (NCT07218497) | University of Southern California | 2025-11-01 |
| Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) (NCT07142044) | EicOsis Human Health Inc. | 2025-11-01 |
| A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. (NCT06641648) | Peking University First Hospital | 2025-11-01 |
| Effect of Dexmedetomidine on Acute Kidney Injury After Ascending Aortic Surgeries (NCT06958367) | Ain Shams University | 2025-11-01 |
| Phase I/II Clinical Study of GT201 Injection as Monotherapy or in Combination With PD-1 Inhibitor for Advanced Solid Tumors (NCT06144671) | Grit Biotechnology | 2025-11-01 |
| Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia (NCT06644573) | Nyree Penn | 2025-11-01 |
| A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure (NCT07230145) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-11-01 |
| Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome (NCT07270549) | CTNNB1 Foundation | 2025-11-01 |
| Assessment of the Dose Safety and Efficacy of Serine Combined With Fluorouracil Drugs (NCT07178613) | The First Affiliated Hospital of Xinxiang Medical College | 2025-11-01 |
| Dapagliflozin in Depression (NCT07239011) | Tanta University | 2025-11-01 |
| Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma (NCT06468605) | Duke University | 2025-11-01 |
| Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial (NCT07190027) | First Affiliated Hospital of Wenzhou Medical University | 2025-11-01 |
| A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects (NCT07007520) | Dong-A ST Co., Ltd. | 2025-11-01 |
| An Initial Evaluation of AN8025 in Solid Tumors (NCT07639047) | Adlai Nortye Biopharma Co., Ltd. | 2025-11-01 |
| Air-Dried Human Amniotic Membrane Terminally Sterilized by Gamma Irradiation for Multidisciplinary Clinical Application (NCT07466576) | Libyan Center for Biotechnology Research | 2025-11-01 |
| Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools (NCT06935149) | Primo Biotechnology Co., Ltd | 2025-10-31 |
| 68Ga-GP-01 Injection in Solid Tumors Participants (NCT07045428) | GrandPharma (China) Co., Ltd. | 2025-10-31 |
| FACE Phase II (a Stage II Trial) (NCT07130669) | Stanford University | 2025-10-31 |
| A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors (NCT06640413) | Philogen S.p.A. | 2025-10-31 |
| Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer (NCT06393751) | National Cancer Institute (NCI) | 2025-10-31 |
| Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate (NCT07158398) | Deciphera Pharmaceuticals, LLC | 2025-10-31 |
| Effects of High-Fiber Diet on Gut Microbiota, Metabolism, and Immune Microenvironment in Solid Tumor Patients: A Clinical Study (NCT07477522) | West China Hospital | 2025-10-31 |
| A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects. (NCT07205198) | Shanghai Institute Of Biological Products | 2025-10-31 |
| Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) (NCT07036003) | Dr. David Wasserstein | 2025-10-31 |
| NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis (NCT04129515) | Brown University | 2025-10-30 |
| A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors (NCT07182149) | Normunity AccelCo, Inc. | 2025-10-30 |
| Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease (NCT07310264) | Vertero Therapeutics | 2025-10-30 |
| Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers (NCT07304726) | Chong Kun Dang Pharmaceutical | 2025-10-30 |
| Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration (NCT07232758) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-30 |
| A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms (NCT07200479) | Institute of Hematology & Blood Diseases Hospital, China | 2025-10-30 |
| An Exploratory Study of Golidocitinib in Adult Patients With ITP (NCT07196163) | Peking University People's Hospital | 2025-10-30 |
| Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects (NCT07181265) | Jemincare | 2025-10-30 |
| A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease (NCT07231679) | Ingenia Therapeutics INC | 2025-10-30 |
| Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients (NCT04480619) | Advanced Imaging Projects, LLC | 2025-10-30 |
| Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases (NCT06675136) | City of Hope Medical Center | 2025-10-29 |
| Bioequivalence Study of WP205 in Healthy Participants (NCT07281872) | Wanbangde Pharmaceutical Group Co., LTD | 2025-10-29 |
| Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients (NCT07096609) | Asan Medical Center | 2025-10-29 |
| A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome (NCT07181837) | MavriX Bio, LLC | 2025-10-29 |
| Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis (NCT07250269) | Gracell Biotechnologies (Shanghai) Co., Ltd. | 2025-10-29 |
| A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects (NCT07185113) | GEn1E Lifesciences | 2025-10-29 |
| Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD (NCT06233110) | Stefanie Sarantopoulos, MD, PhD. | 2025-10-29 |
| New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies. (NCT07110662) | Hospices Civils de Lyon | 2025-10-29 |
| A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors (NCT07208773) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2025-10-29 |
| Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD (NCT06878560) | United Therapeutics | 2025-10-29 |
| Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers (NCT07304700) | Chong Kun Dang Pharmaceutical | 2025-10-28 |
| To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects (NCT07371065) | Luye Pharma Group Ltd. | 2025-10-28 |
| Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma (NCT07369895) | O&D BioTech Group CO., Limited | 2025-10-28 |
| A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants (NCT07221084) | Crinetics Pharmaceuticals Inc. | 2025-10-28 |
| Study of Cannabidiol and Neuroimaging on Stress (NCT07278505) | Icahn School of Medicine at Mount Sinai | 2025-10-28 |
| A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004) (NCT07199452) | Merck Sharp & Dohme LLC | 2025-10-28 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants (NCT07237464) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2025-10-28 |
| Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes (NCT07090824) | Stanford University | 2025-10-28 |
| Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung (NCT05717140) | Mayo Clinic | 2025-10-28 |
| Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma (NCT07377045) | Oncomatryx Biopharma S.L. | 2025-10-28 |
| Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans (NCT07331194) | Hutchmed | 2025-10-28 |
| A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin (NCT07235189) | Daiichi Sankyo | 2025-10-28 |
| Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions (NCT07251153) | Enyo Pharma | 2025-10-28 |
| A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor (NCT07140393) | Jiangsu HengRui Medicine Co., Ltd. | 2025-10-28 |
| Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) (NCT07139990) | University of Texas Southwestern Medical Center | 2025-10-28 |